Important update on Friday 13 November: Microsoft disruption

Please be aware, many of our staff are unable to access emails. Due to a wider Microsoft disruption, our emails (Outlook) and other services may not be working as normal.

Read more about the disruption

Disease-modifying anti-Rheumatic Drugs and Immunosuppressants MSS3

Medication Safety Series: MSS 3 - Disease-modifying anti-Rheumatic Drugs and Immunosuppressants. This covers On-Admission, During-Admission and On Discharge / prolonged leave.